FDA, CMS To Begin Collaborating On Drug Safety Data Collection In 2005
Executive Summary
FDA will begin using drug safety information collected by the Centers for Medicare & Medicaid Services in 2005
You may also be interested in...
FDA Personnel Moves Signal Continuity Under Commissioner Crawford
Five top-level FDA personnel appointments implemented July 29 suggest general agency policy will likely go unchanged in the near future
FDA Personnel Moves Signal Continuity Under Commissioner Crawford
Five top-level FDA personnel appointments implemented July 29 suggest general agency policy will likely go unchanged in the near future
CMS Reimbursement Tied To Data Collection Could Speed Coverage Decisions
Medicare reimbursement that is linked to requirements for post-marketing data collection could allow for faster coverage decisions on new medical products, American Enterprise Institute Resident Fellow Scott Gottlieb said at a Biotechnology Industry Organization/Windhover conference in Washington, D.C. April 27